P2P, or not P2P, that is the question
As the 16 January, 2015 deadline for responding to the controversial P2P draft report draws near, and in the interests of balance and representing the whole community, Phoenix Rising presents two differing views on how to react. Today, Clark Ellis flags up important content to...
Discuss the article on the Forums.

Hemispherx Announces 9th Clinical Investigators Conference: Trials Highlighted

Discussion in 'Latest ME/CFS Research' started by JohnnyD, Mar 7, 2011.

  1. JohnnyD

    JohnnyD Senior Member

    Hemispherx Biopharma Announces 9th Clinical Investigators Conference: Ampligen Clinical Trials Highlighted

    Dr. Judy Mikovits, Research Director, Whittemore Peterson Institute for Neuro-Immune Disease, presented a detailed review of the discovery of XMRV ("Xenotropic Murine Leukemia Virus") and MLV ("Murine Leukemia Viruses') variants found in CFS, as well as new data on these variants. The XMRV genome may contain a hormonal response element that may explain the disorder of the adrenal stress response pathway in some patients with CFS. Dr. Mikovits also discussed a cellular resistance mechanism as a possible human genetic factor in XMRV infection.

  2. LaurelW

    LaurelW Senior Member

    Wow-who knew they were using Ampligen for all those vaccines? I wonder if this will make it easier for it to get approved.
  3. heapsreal

    heapsreal iherb 10% discount code OPA989,

    australia (brisbane)
    the interferon inducer cycloferon is used with vaccines as well as the body then produces strong antibody response, maybe this is how ampligen works as it inducers interferon as well. Also mentioning the adrenal stress response, mmm sounds abit like adrenal fatigue type stuff, looks like their confirming alot of these we on here are trying to treat ourselves.

See more popular forum discussions.

Share This Page